1. Home
  2. HALO vs DSGX Comparison

HALO vs DSGX Comparison

Compare HALO & DSGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HALO
  • DSGX
  • Stock Information
  • Founded
  • HALO 1998
  • DSGX 1981
  • Country
  • HALO United States
  • DSGX Canada
  • Employees
  • HALO N/A
  • DSGX N/A
  • Industry
  • HALO Biotechnology: Biological Products (No Diagnostic Substances)
  • DSGX Computer Software: Prepackaged Software
  • Sector
  • HALO Health Care
  • DSGX Technology
  • Exchange
  • HALO Nasdaq
  • DSGX Nasdaq
  • Market Cap
  • HALO 7.6B
  • DSGX 8.4B
  • IPO Year
  • HALO N/A
  • DSGX 1999
  • Fundamental
  • Price
  • HALO $68.24
  • DSGX $84.05
  • Analyst Decision
  • HALO Buy
  • DSGX Buy
  • Analyst Count
  • HALO 11
  • DSGX 9
  • Target Price
  • HALO $74.91
  • DSGX $123.11
  • AVG Volume (30 Days)
  • HALO 2.2M
  • DSGX 642.2K
  • Earning Date
  • HALO 11-03-2025
  • DSGX 12-03-2025
  • Dividend Yield
  • HALO N/A
  • DSGX N/A
  • EPS Growth
  • HALO 56.68
  • DSGX 14.17
  • EPS
  • HALO 4.74
  • DSGX 1.69
  • Revenue
  • HALO $1,242,852,000.00
  • DSGX $684,781,000.00
  • Revenue This Year
  • HALO $32.47
  • DSGX $11.82
  • Revenue Next Year
  • HALO $24.31
  • DSGX $11.25
  • P/E Ratio
  • HALO $14.41
  • DSGX $49.92
  • Revenue Growth
  • HALO 31.19
  • DSGX 12.69
  • 52 Week Low
  • HALO $42.01
  • DSGX $82.96
  • 52 Week High
  • HALO $79.50
  • DSGX $124.31
  • Technical
  • Relative Strength Index (RSI)
  • HALO 56.09
  • DSGX 26.56
  • Support Level
  • HALO $67.40
  • DSGX $95.02
  • Resistance Level
  • HALO $66.97
  • DSGX $97.36
  • Average True Range (ATR)
  • HALO 2.04
  • DSGX 2.22
  • MACD
  • HALO 0.51
  • DSGX -1.03
  • Stochastic Oscillator
  • HALO 71.78
  • DSGX 7.39

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.

About DSGX Descartes Systems Group Inc. (The)

Descartes Systems Group provides a software solution that allows users in the shipping industry to communicate with one another. Its core product is the Global Logistics Network, which is best understood as transaction-driven. Descartes charges clients to send/receive messages, data, and documents on the GLN. Customers typically contract for a monthly minimum over a multiyear period. The GLN platform allows Descartes to upsell additional software modules as well, typically provided via a software-as-a-service model.

Share on Social Networks: